Literature DB >> 6687550

Pharmacokinetics of atracurium besylate in healthy patients (after a single i.v. bolus dose).

S Ward, E A Neill, B C Weatherley, I M Corall.   

Abstract

The plasma decay of atracurium besylate was examined in two groups of six patients. Group I received atracurium 0.6 mg kg-1 and group II 0.3 mg kg-1 as a single bolus dose i.v. The plasma concentrations were measured by high performance liquid chromatography. An individual two-compartment pharmacokinetic model was used for interpretation. The results from the two groups were not significantly different, giving overall mean values of 2 min (+/- 0.2 SEM) for the distribution half-life (T1/2 alpha), 19.9 min (+/- 0.6) for the elimination half-life (T1/2 beta), 5.5 ml min-1 kg-1 (+/- 0.2) for total clearance (Cl) and 157 ml kg-1 (+/- 7) for total distribution volume (Varea).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687550     DOI: 10.1093/bja/55.2.113

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

1.  Assuming peripheral elimination: its impact on the estimation of pharmacokinetic parameters of muscle relaxants.

Authors:  J Laurin; F Nekka; F Donati; F Varin
Journal:  J Pharmacokinet Biopharm       Date:  1999-10

2.  Quantitative determination of atracurium in human plasma using high-performance liquid chromatography.

Authors:  R Okutani; K Kono; F M DeBros; D M Philbin
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

3.  Pharmacokinetics of atracurium besylate in the pig after a single i.v. injection.

Authors:  C Schopfer; J F Pittet; D R Morel; E Tassonyi; A Benakis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Oct-Dec       Impact factor: 2.441

Review 4.  Clinical pharmacokinetics of neuromuscular blocking drugs.

Authors:  S Agoston; R H Vandenbrom; J M Wierda
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

Review 5.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

6.  Hipocrates: a robust system for the control of neuromuscular blockade.

Authors:  Teresa Mendonça; Hugo Magalhães; Pedro Lago; Simão Esteves
Journal:  J Clin Monit Comput       Date:  2004-08       Impact factor: 2.502

7.  Atracurium and vecuronium interaction with gentamicin and tobramycin.

Authors:  J Y Dupuis; R Martin; J P Tétrault
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

Review 8.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.